Distinct MicroRNAs Expression Profile in Primary Biliary Cirrhosis and Evaluation of miR 505-3p and miR197-3p as Novel Biomarkers

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Ninomiya, Masashi ^a   Kondo, Yasuteru ^a   Funayama, Ryo ^b   Nagashima, Takeshi ^b   Kogure, Takayuki ^a   Kakazu, Eiji ^a   Kimura, Osamu ^a   Ueno, Yoshiyuki ^c   Nakayama, Keiko ^b   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 197; MICRORNA 505; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MAPPING; GENE TARGETING; GENETIC VARIABILITY; HUMAN; MALE; PRIMARY BILIARY CIRRHOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; STATISTICAL SIGNIFICANCE; VALIDATION STUDY; VIRUS HEPATITIS;

AGED; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84878919588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066086     Document Type: Article

References (56)

1. Lau NC, Lim LP, Weinstein EG, Bartel DP, (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862.
2. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T, (2001) Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
3. Lee RC, Ambros V, (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864.
4. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
5. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 18: 997-1006.
6. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
7. Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, et al. (2011) Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 106: 1663-1669.
8. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, et al. (2010) Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56: 1830-1838.
9. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L, (2011) Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease. PLoS One 6: e23937.
10. Morita K, Taketomi A, Shirabe K, Umeda K, Kayashima H, et al. (2011) Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int 31: 474-484.
11. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, et al. (2010) Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma. Cancer Research 70: 9798-9807.
12. Nakanuma Y, Ohta G, (1979) Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 76: 1326-1332.
13. Gershwin ME, Mackay IR, Sturgess A, Coppel RL, (1987) Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138: 3525-3531.
14. Coppel RL, McNeilage LJ, Surh CD, Van de Water J, Spithill TW, et al. (1988) Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci U S A 85: 7317-7321.
15. Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, et al. (2004) Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127: 485-492.
16. Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, et al. (1994) Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 43: 71-77.
17. Donaldson PT, Baragiotta A, Heneghan MA, Floreani A, Venturi C, et al. (2006) HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 44: 667-674.
18. Onishi S, Sakamaki T, Maeda T, Iwamura S, Tomita A, et al. (1994) DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol 21: 1053-1060.
19. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, et al. (2009) Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360: 2544-2555.
20. Mells GF, Floyd JA, Morley KI, Cordell HJ, Franklin CS, et al. (2011) Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 43: 329-332.
21. Hirschfield G, Invernizzi P, (2011) Progress in the Genetics of Primary Biliary Cirrhosis. Seminars in Liver Disease 31: 147-156.
22. Nakamura M, Nishida N, Kawashima M, Aiba Y, Tanaka A, et al. (2012) Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population. Am J Hum Genet 91: 721-728.
23. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, et al. (2009) Primary biliary cirrhosis. Hepatology 50: 291-308.
24. Corpechot C, Poupon R, (2007) Geotherapeutics of primary biliary cirrhosis: Bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom. Hepatology 46: 963-965.
25. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, et al. (1996) Natural history of early primary biliary cirrhosis. Lancet 348: 1399-1402.
26. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
27. Martin M, (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet journal 17: 10-12.
28. Robinson MD, Oshlack A, (2010) A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biology 11: R25.
29. Balaga O, Friedman Y, Linial M, (2012) Toward a combinatorial nature of microRNA regulation in human cells. Nucleic Acids Res 40: 9404-9416.
30. Juran BD, Lazaridis KN, (2010) Update on the genetics and genomics of PBC. J Autoimmun 35: 181-187.
31. Zhang R, Peng Y, Wang W, Su B, (2007) Rapid evolution of an X-linked microRNA cluster in primates. Genome Res 17: 612-617.
32. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences 105: 10513-10518.
33. Ai J, Zhang R, Li Y, Pu J, Lu Y, et al. (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and Biophysical Research Communications 391: 73-77.
34. Chim SSC, Shing TKF, Hung ECW, Leung Ty, Lau Tk, et al. (2008) Detection and Characterization of Placental MicroRNAs in Maternal Plasma. Clinical Chemistry 54: 482-490.
35. Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DGN, et al. (2011) Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54: 1767-1776.
36. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, et al. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proceedings of the National Academy of Sciences 106: 4402-4407.
37. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, et al. (2010) Circulating microRNAs in plasma of patients with gastric cancers. British Journal of Cancer 102: 1174-1179.
38. Kong X, Du Y, Wang G, Gao J, Gong Y, et al. (2010) Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis. Digestive Diseases and Sciences 56: 602-609.
39. Silva J, Garcia V, Zaballos A, Provencio M, Lombardia L, et al. (2010) Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. European Respiratory Journal 37: 617-623.
40. Li M, Marin-Muller C, Bharadwaj U, Chow K-H, Yao Q, et al. (2008) MicroRNAs: Control and Loss of Control in Human Physiology and Disease. World Journal of Surgery 33: 667-684.
41. Berg CP, Stein GM, Keppeler H, Gregor M, Wesselborg S, et al. (2007) Apoptosis-associated antigens recognized by autoantibodies in patients with the autoimmune liver disease primary biliary cirrhosis. Apoptosis 13: 63-75.
42. Liang Y, Yang Z, Li C, Zhu Y, Zhang L, et al. (2008) Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis. Clinical and Experimental Medicine 8: 1-7.
43. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
44. Nakagome Y, Ueno Y, Kogure T, Fukushima K, Moritoki Y, et al. (2007) Autoimmune cholangitis in NOD.c3c4 mice is associated with cholangiocyte-specific Fas antigen deficiency. J Autoimmun 29: 20-29.
45. Singh R, Bullard J, Kalra M, Assefa S, Kaul AK, et al. (2011) Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers. Clinical Immunology 138: 41-49.
46. Kyriakou DS, Alexandrakis MG, Zachou K, Passam F, Stathakis NE, et al. (2003) Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 39: 679-685.
47. Maglott D, Ostell J, Pruitt KD, Tatusova T, (2010) Entrez Gene: gene-centered information at NCBI. Nucleic Acids Research 39: D52-D57.
48. Kozomara A, Griffiths-Jones S, (2010) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Research 39: D152-D157.
49. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 57: 289-300.
50. Team RDC (2011) R: a language and environment for statistical computing. Vienna, Austria: the R Foundation for Statistical Computing.
51. Friedman Y, Naamati G, Linial M, (2010) MiRror: a combinatorial analysis web tool for ensembles of microRNAs and their targets. Bioinformatics 26: 1920-1921.
52. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
53. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, et al. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431-435.
54. Ludwig J, Dickson ER, McDonald GS, (1978) Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379: 103-112.
55. Scheuer P, (1967) Primary biliary cirrhosis. Proceedings of the Royal Society of Medicine 60: 1257-1260.
56. Ward JH, (1963) Hierarchical Grouping to Optimize an Objective Function. Journal of the American Statistical Association 58: 236-244.